524711 — Vista Pharmaceuticals Balance Sheet
0.000.00%
- IN₹382.24m
- IN₹481.04m
- IN₹54.00m
Annual balance sheet for Vista Pharmaceuticals, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
C2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 0.719 | 2.04 | 0.944 | 7.33 | 1.07 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 105 | 113 | 143 | 33.9 | 3.17 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 236 | 238 | 234 | 148 | 154 |
| Net Property, Plant And Equipment | 189 | 195 | 196 | 193 | 193 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 556 | 560 | 580 | 603 | 551 |
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 126 | 141 | 145 | 124 | 166 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 201 | 193 | 175 | 149 | 186 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 355 | 367 | 405 | 454 | 364 |
| Total Liabilities & Shareholders' Equity | 556 | 560 | 580 | 603 | 551 |
| Total Common Shares Outstanding |